These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3576 related articles for article (PubMed ID: 20530316)

  • 21. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study.
    Granata R; Miceli R; Orlandi E; Perrone F; Cortelazzi B; Franceschini M; Locati LD; Bossi P; Bergamini C; Mirabile A; Mariani L; Olmi P; Scaramellini G; Potepan P; Quattrone P; Ang KK; Licitra L
    Ann Oncol; 2012 Jul; 23(7):1832-7. PubMed ID: 22115925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
    Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
    Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
    Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
    Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case-control study of human papillomavirus and oropharyngeal cancer.
    D'Souza G; Kreimer AR; Viscidi R; Pawlita M; Fakhry C; Koch WM; Westra WH; Gillison ML
    N Engl J Med; 2007 May; 356(19):1944-56. PubMed ID: 17494927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
    Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
    Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients.
    Ukpo OC; Pritchett CV; Lewis JE; Weaver AL; Smith DI; Moore EJ
    Ann Otol Rhinol Laryngol; 2009 May; 118(5):368-73. PubMed ID: 19548387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.
    Fakhry C; Zhang Q; Nguyen-Tan PF; Rosenthal D; El-Naggar A; Garden AS; Soulieres D; Trotti A; Avizonis V; Ridge JA; Harris J; Le QT; Gillison M
    J Clin Oncol; 2014 Oct; 32(30):3365-73. PubMed ID: 24958820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
    Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
    Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.
    Platek AJ; Jayaprakash V; Merzianu M; Platek ME; Cohan DM; Hicks WL; Marimuthu SP; Winslow TB; Gupta V; Arshad H; Kuriakose MA; Dibaj S; Marshall JR; Reid ME; Warren GW; Singh AK
    Laryngoscope; 2016 Dec; 126(12):2733-2738. PubMed ID: 27346612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
    Lassen P; Lacas B; Pignon JP; Trotti A; Zackrisson B; Zhang Q; Overgaard J; Blanchard P;
    Radiother Oncol; 2018 Jan; 126(1):107-115. PubMed ID: 29100700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma.
    Mazul AL; Rodriguez-Ormaza N; Taylor JM; Desai DD; Brennan P; Anantharaman D; Gheit T; Tommasino M; Abedi-Ardekani B; Olshan AF; Zevallos JP
    Oral Oncol; 2016 Oct; 61():98-103. PubMed ID: 27688111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus-stratified analysis of the prognostic role of miR-21 in oral cavity and oropharyngeal squamous cell carcinoma.
    Ko YH; Won HS; Sun DS; An HJ; Jeon EK; Kim MS; Lee HH; Kang JH; Jung CK
    Pathol Int; 2014 Oct; 64(10):499-507. PubMed ID: 25236707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
    Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
    Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.
    Ross RB; Koyfman SA; Reddy CA; Houston N; Geiger JL; Woody NM; Joshi NP; Greskovich JF; Burkey BB; Scharpf J; Lamarre ED; Prendes B; Lorenz RR; Adelstein DJ; Ward MC
    Laryngoscope; 2018 Jun; 128(6):1379-1385. PubMed ID: 29086413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 179.